[1]
Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, and Salman Khan, “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”, J Popl Ther Clin Pharmacol, vol. 28, no. 2, pp. 418–422, Jul. 2021, doi: 10.53555/jptcp.v28i2.6807.